Correction

Published on 09 May 2023

Corrigendum: Clostridium butyricum protects against pancreatic and intestinal injury after severe acute pancreatitis via downregulation of MMP9

in Inflammation Pharmacology

Qingqing Yan
Lin Jia
Biyan Wen
Yao Wu
Yanbo Zeng
Qing Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1197442

964 views

Correction

Published on 09 May 2023

Corrigendum: Cell volume restriction by mercury chloride reduces M1-like inflammatory response of bone marrow-derived macrophages

in Inflammation Pharmacology

Yen-Chieh Chuang
Shu-Yu Wu
Yu-Chuan Huang
Chung-Kan Peng
Shih-En Tang
Kun-Lun Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1210999

874 views

Brief Research Report

Published on 09 May 2023

Continuous IV infusion of anakinra

in Inflammation Pharmacology

Brittney N. Saunders
Marcela V. Kuijpers
Jason J. Sloan
Elie Gertner

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1162742

4,670 views
4 citations

Review

Published on 09 May 2023

Phytochemicals in the treatment of inflammation-associated diseases: the journey from preclinical trials to clinical practice

in Inflammation Pharmacology

Akib Nisar
Suresh Jagtap
Suresh Vyavahare
Manasi Deshpande
Abhay Harsulkar
Prabhakar Ranjekar
Om Prakash

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1177050

9,208 views
22 citations

Mini Review

Published on 04 May 2023

One stone two birds: anti-inflammatory bronchodilators as a potential pharmacological strategy for COVID-19

in Inflammation Pharmacology

Yuanyuan Yu
Bangjiang Fang
Xiao-Dong Yang
Yuejuan Zheng

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1185076

7,752 views
3 citations

Review

Published on 04 May 2023

Efficacy and safety of abrocitinib for moderate-to-severe atopic dermatitis in adolescents and adults: Meta-analysis

in Inflammation Pharmacology

Ling Li
Jiajun Yu
Baoqing Chen
Ying Guo
Yufeng Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1154949

4,633 views
2 citations

Review

Published on 02 May 2023

Hypoxia inducible factor prolyl hydroxylases in inflammatory bowel disease

in Inflammation Pharmacology

Jie Lun
Hongwei Zhang
Jing Guo
Mengchao Yu
Jing Fang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1045997

3,352 views
4 citations

Original Research

Published on 26 Apr 2023

Flurbiprofen inhibits heme induced NLRP3 inflammasome in Berkeley sickle cell disease mice

in Inflammation Pharmacology

Dilpreet Kour
Mehboob Ali
Parul Khajuria
Kuhu Sharma
Palash Ghosh
Sukhleen Kaur
Surbhi Mahajan
P. Ramajayan
Sonali S. Bharate
Subhash Bhardwaj

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1123734

2,934 views
1 citation

Review

Published on 21 Apr 2023

Immunomodulatory biomaterials on chemokine signaling in wound healing

in Inflammation Pharmacology

Anisha Apte
Kenneth W. Liechty
Carlos Zgheib

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1084948

2,827 views
11 citations

Original Research

Published on 21 Apr 2023

P2X7 receptor contributes to long-term neuroinflammation and cognitive impairment in sepsis-surviving mice

in Inflammation Pharmacology

Vinícius Santos Alves
Joyce Pereira da Silva
Fabiana Cristina Rodrigues
Suzana Maria Bernardino Araújo
André Luiz Gouvêa
Raíssa Leite-Aguiar
Stephanie Alexia Cristina Silva Santos
Milla Souza Pessoa da Silva
Fernanda Silva Ferreira
Eduardo Peil Marques

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1179723

3,500 views
9 citations

Original Research

Published on 20 Apr 2023

N-benzyl-N-methyldecan-1-amine and its derivative mitigate 2,4- dinitrobenzenesulfonic acid-induced colitis and collagen-induced rheumatoid arthritis

in Inflammation Pharmacology

Ji Eun Kim
Changyu Kang
Phatcharaporn Budluang
Natpaphan Yawut
Il-Rae Cho
Yun Ju Choi
Jaejeong Kim
Sanghyun Ju
Beomgu Lee
Dong Hyun Sohn

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1095955

2,774 views
2 citations

Original Research

Published on 19 Apr 2023

Positive allosteric adenosine A2A receptor modulation suppresses insomnia associated with mania- and schizophrenia-like behaviors in mice

in Inflammation Pharmacology

Yang Lin
Koustav Roy
Shuji Ioka
Rintaro Otani
Mao Amezawa
Yukiko Ishikawa
Yoan Cherasse
Mahesh K. Kaushik
Daniela Klewe-Nebenius
Li Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1138666

4,045 views
5 citations

Systematic Review

Published on 18 Apr 2023

Efficacy and safety of Omega-3 polyunsaturated fatty acids in adjuvant treatments for colorectal cancer: A meta-analysis of randomized controlled trials

in Inflammation Pharmacology

Haoshuang Liu
Jingfeng Chen
Weihao Shao
Su Yan
Suying Ding

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1004465

3,826 views
9 citations

Original Research

Published on 18 Apr 2023

Lycium barbarum polysaccharide alleviates dextran sodium sulfate-induced inflammatory bowel disease by regulating M1/M2 macrophage polarization via the STAT1 and STAT6 pathways

in Inflammation Pharmacology

Juan Wang
Huiying Gao
Yuan Xie
Peng Wang
Yu Li
Junli Zhao
Chunlin Wang
Xin Ma
Yuwen Wang
Qinwen Mao

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1044576

3,969 views
13 citations

Original Research

Published on 12 Apr 2023

Anti-hyperuricemia effect of hesperetin is mediated by inhibiting the activity of xanthine oxidase and promoting excretion of uric acid

in Inflammation Pharmacology

Meng-Fei An
Chang Shen
Shao-Shi Zhang
Ming-Yue Wang
Ze-Rui Sun
Mao-Si Fan
Li-Juan Zhang
Yun-Li Zhao
Jun Sheng
Xuan-Jun Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1128699

4,094 views
8 citations

Clinical Trial

Published on 11 Apr 2023

Evaluating the safety and efficacy of the leukotriene receptor antagonist montelukast as adjuvant therapy in obese patients with type 2 diabetes mellitus: A double-blind, randomized, placebo-controlled trial

in Inflammation Pharmacology

Eman El-Khateeb
Eman I. El-Berri
Esraa M. Mosalam
Mohamed Z. Nooh
Shimaa Abdelsattar
Amira M. Alghamdi
Sarah Alrubia
Mahmoud S. Abdallah

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1153653

7,072 views
4 citations

Navigation group

Articles

Corrigendum: Clostridium butyricum protects against pancreatic and intestinal injury after severe acute pancreatitis via downregulation of MMP9

Corrigendum: Cell volume restriction by mercury chloride reduces M1-like inflammatory response of bone marrow-derived macrophages

Continuous IV infusion of anakinra

Phytochemicals in the treatment of inflammation-associated diseases: the journey from preclinical trials to clinical practice

One stone two birds: anti-inflammatory bronchodilators as a potential pharmacological strategy for COVID-19

Efficacy and safety of abrocitinib for moderate-to-severe atopic dermatitis in adolescents and adults: Meta-analysis

Hypoxia inducible factor prolyl hydroxylases in inflammatory bowel disease

Flurbiprofen inhibits heme induced NLRP3 inflammasome in Berkeley sickle cell disease mice

Immunomodulatory biomaterials on chemokine signaling in wound healing

P2X7 receptor contributes to long-term neuroinflammation and cognitive impairment in sepsis-surviving mice

N-benzyl-N-methyldecan-1-amine and its derivative mitigate 2,4- dinitrobenzenesulfonic acid-induced colitis and collagen-induced rheumatoid arthritis

Positive allosteric adenosine A2A receptor modulation suppresses insomnia associated with mania- and schizophrenia-like behaviors in mice

Efficacy and safety of Omega-3 polyunsaturated fatty acids in adjuvant treatments for colorectal cancer: A meta-analysis of randomized controlled trials

Lycium barbarum polysaccharide alleviates dextran sodium sulfate-induced inflammatory bowel disease by regulating M1/M2 macrophage polarization via the STAT1 and STAT6 pathways

Anti-hyperuricemia effect of hesperetin is mediated by inhibiting the activity of xanthine oxidase and promoting excretion of uric acid

Evaluating the safety and efficacy of the leukotriene receptor antagonist montelukast as adjuvant therapy in obese patients with type 2 diabetes mellitus: A double-blind, randomized, placebo-controlled trial